Publications by authors named "Colleen Timlin"

Claim this Profile
C
Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies.
Matthew P Connor, Alison W Loren, Elizabeth O Hexner, Mary Ellen Martin, Saar I Gill, Colleen Timlin

Transplant Cell Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide.
Craig W Freyer, Alison Carulli, Shannon Gier, Alex Ganetsky, Colleen Timlin

Leuk Lymphoma· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay.
Craig W Freyer, Shannon Gier, Mary E Moyer, Natasha Berryman, Alison Carulli, Colleen Timlin

Transplant Cell Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation.
Craig W Freyer, Alison Carulli, Alex Ganetsky, Mitchell E Hughes, Tracy M Krause, Colleen Timlin

Leuk Lymphoma· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
American Society for Transplantation and Cellular Therapy Pharmacy Special Interest Group Position Statement on Pharmacy Practice Management and Clinical Management for COVID-19 in Hematopoietic Cell Transplantation and Cellular Therapy Patients in the United States.
Zahra Mahmoudjafari, Maurice Alexander, Julianna Roddy, Ryan Shaw, Terri Lynn Shigle, Colleen Timlin

Biol Blood Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
Alex Ganetsky, Noelle V Frey, Elizabeth O Hexner, Alison W Loren, Saar I Gill, Colleen Timlin

Bone Marrow Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia.
Erin Bange, Colleen Timlin, Charlene Kabel, Jakub Svoboda, Lindsey Roeker

Clin Lymphoma Myeloma Leuk· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicities and outcomes of 616 ibrutinib-treated patients in the United States: a real-world analysis.
Anthony R Mato, Chadhi Nabhan, Meghan C Thompson, Nicole Lamanna, Danielle M Brander, Colleen Timlin

Haematologica· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced-dose ibrutinib: results from a multi-centre study.
Anthony R Mato, Colleen Timlin, Chaitra Ujjani, Alan Skarbnik, Christina Howlett

Br J Haematol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of next generation sequencing identifies potentially actionable mutations in chronic lymphocytic leukaemia.
Jie Wang, Jennifer Morrissette, David B Lieberman, Colleen Timlin, Stephen J Schuster

Br J Haematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis